ISRCTN80764175CompletedNot Applicable
onger term clinical and economic benefits of offering acupuncture to patients with chronic low back pai
Department of Health (UK)0 sites200 target enrollmentStarted: April 25, 2003Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Patients with low back pain. Age 20-65 years with low back pain or sciatica, greater than 4 weeks and less than 12-months pain this episode
Exclusion Criteria
- •Past spinal surgery, severe or progressive motor weakness or central disc prolapse, possible spinal pathology (eg carcinoma)
Investigators
Similar Trials
Active, not recruiting
Phase 4
Study of the effectiveness and safety of treatments to help patients with anaemia recover from major emergency surgery. Perioperative Iron and ESA Intervention Study (POP-I).Post-operative anaemiaHaematological DisordersISRCTN24330080ottingham Clinical Trials Unit2,400
Recruiting
Not Applicable
Evidence of the medical and economic benefits of implementing hygiene measures by hygienic physicians in trauma surgery/orthopedicsAssessment of the effectiveness of existing measures to prevent antibiotic resistance and nosocomial infectionsDRKS00013296Kliniken der Stadt Köln gGmbH, Institut für Hygiene7,000
Active, not recruiting
Phase 1
What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin?pper limb spasticity following strokeEUCTR2004-002427-40-GBewcastle Upon Tyne Hospitals NHS Foundation Trust332
Completed
Not Applicable
What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin?pper limb spasticity due to strokeCirculatory SystemStrokeISRCTN78533119The Newcastle Upon Tyne Hospitals NHS Foundation Trust (UK)390
Not yet recruiting
Unknown
Evaluation of medical benefits and positive effects on patient supply of the certified medical product PINK! Leben in a multi-centre, randomized controlled trial with breast cancer patientsDRKS00031243PINK! gegen Brustkrebs194